Recombinant Erythropoiesis Stimulating Protein Injection(CHO cell)

DRUG2 trials

Sponsors

Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions

Chronic Renal Failure With HemodialysisHemodialysisKidney Failure, Chronic

Phase 2

Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Shenyang Sunshine Pharmaceutical Co., LTD.Chronic Renal Failure With Hemodialysis

Start: 2019-06-24End: 2020-12-30Target: 150Updated: 2020-03-09

Phase 3

Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure

Shenyang Sunshine Pharmaceutical Co., LTD.Hemodialysis, Kidney Failure, Chronic

Start: 2021-07-01End: 2023-12-30Target: 300Updated: 2022-01-27